While both dobutamine and pacing tachycardia augment left ventricular (LV) contractility, whether overall cardiovascular response to these stimuli is comparable is not known. To address this question we studied seven dogs previously instrumented with three LV diameter gauges and LV pressure manometers. After ganglionic blockade and sedation, caval occlusions were performed at heart rates of 120, 160, and 200 bpm before (C), and 160 and 200 bpm after administration of 10 ag/kg per min dobutamine, i.v. (D). The effective arterial elastance (E.) went up from 14.2±4.5 mmHg/ml at C120 to 19.6±8.8 (P < 0.025 vs C120) and 24.2±10.4 (P < 0.001 vs C120) mmHg/ml at C160 and C200. E", the slope of the end-systolic pressure-volume relation, increased with pacing from 9.7±4.6 to 11.7±43 (P < 0.02), and 13.2±5.7 (P < 0.02) mmHg/ml at 160 and 200 bpm. With dobutamine infusion E. went down, and E., was further increased to 37.0±20.9 mmHg/ml at 160 bpm (P < 0.002 vs C160), and 53.0±22.6 mmHg/ml at 200 bpm (P < 0.002 vs C200). Comparison of stroke work and pressure-volume area from single beats with matched LV end-diastolic volumes showed that these were both increased by dobutamine, but not by pacing tachycardia. While increased heart rate after dobutamine markedly increased contractility, E. was not changed, and neither stroke work nor pressure-volume was further increased. Thus, how well an increase in contractility is transmitted to the periphery is determined in part by arterial behavior. Assessment of both the arterial system and cardiac contractility is necessary to fully evaluate the overall impact of an inotropic stimulus. (J.
Introduction
Under ordinary conditions in the intact heart, ventricular myocardium does not function at its maximal level of contractile performance. Thus the organism has reserves available, and contractility can be augmented when demand for cardiac performance is increased. Two mechanisms by which this can occur are adrenergic stimulation and increased heart rate, or (1) (2) (3) and in intact hearts (4) (5) (6) have shown that both of these stimuli increase the inotropic state of the myocardium. How effectively this increase in myocardial performance is transmitted to the systemic circulation may be, however, determined to some extent by the vascular bed through the process of ventriculovascular coupling.
By analyzing hemodynamic data in the pressure-volume plane it is possible to gain information on the performance of both the left ventricle (LV) and the circulatory bed. For the LV, contractile performance has been characterized by means of the end-systolic pressure-volume (Pc,,-V,) relation (7), as well as the relation between stroke work (SW) and LV end-diastolic volume (8, 9) . As an extension of the Pes-Ves relation, Suga and colleagues have shown in isolated supported hearts that the area bounded by the Pt-Ves relation and the pressure-volume loop, which they term the pressure-volume area (PVA), is linearly related to myocardial oxygen consumption (10, 1 1). These investigators have also shown in intact dogs that the fraction of the PVA comprised of stroke work is an index of the efficiency of mechanical transfer from the LV to the circulatory bed (12) . Thus, the pressure-volume plane allows evaluation ofthe performance ofthe muscle (contractility) as well as the LV as a pump supplying output to the systemic circulation.
Pressure-volume plane analysis is also useful for assessment of the mechanical behavior of the circulatory bed. Sunagawa and colleagues have shown that effective arterial elastance (Ea) can be estimated from the LV pressure-volume loop (13, 14) . This parameter allows a measure of how much the aortic pressure will rise for a given degree of cardiac ejection. Since the pressure-volume construct provides data on both LV performance and circulatory performance it may be ideal for assessing ventriculovascular responses to stimuli in the intact circulation.
The purpose of this study was to evaluate changes of LV contractility and ventriculovascular coupling that occur in intact, closed-chest dogs after inotropic stimulation by increased stimulation frequency, before and after dobutamine infusion. The results demonstrate that these stimuli have additive effects on LV contractility. The overall circulatory response to each stimulus differed considerably because of different effects on Ea. In particular, the increase in contractility due to tachycardia was only partly transmitted to the arterial circulation because ofthe accompanying arterial response. Thus, in addition to how stimuli affect the heart, their effects on the vascular system should be considered when assessing how they alter overall cardiovascular behavior. The Pfi-V,, relation data were fit applying a linear least-squares algorithm to the equation: P4,,, = Es(V V -VO), where E is the slope of the relation, and V0 its volume axis intercept. To avoid problems that could arise from extrapolation of the Pes-V. relation substantially beyond the data range, the volume at an end-systolic pressure of 100 mmHg, termed V100, was determined from the coefficients defining the linear relation.
Glossary
The slope and volume axis intercepts ofthe SW-EDV relation were determined by linear least-squares algorithm using the equation: SW = Mw(EDV -Vw), where Mw is the slope of the relation, and Vw its volume intercept. Again, to avoid errors which could arise from extrapolating beyond the data range, end-diastolic volume at SW of 1,000 mmHg-ml was determined from the linear coefficients, and termed VwIowo
The PVA was defined as described by Suga et al. (10) , and was calculated for each beat of a caval occlusion run. The efficiency of energy transfer from PVA to external mechanical work was evaluated following the method of Nozawa et al. (12) , using the equation: TransPVA = (SW/PVA) * 100, where TransPvA represents the percentage of the PVA transferred to the circulatory bed.
To avoid confusion which could arise due to interactive effects of changes in both slope and intercept values, the data set was analyzed in a second fashion. For each dog, heart beats with closely matched LVEDV (within 1 ml) were chosen from the five caval occlusion runs. Since the relation between SW and LV end-diastolic volume is linear (8) , comparison of single beat SW and PVA at matched EDV allows assessment of how the heart responded to increased heart rate before and after dobutamine infusion. Also, dP/dtm,, at matched LVEDV was compared, since it has been shown (19) that these parameters are related in a linear fashion.
Effective arterial elastance was defined following the approach of 
Results
Effects ofpacing and dobutamine on myocardial performance.
Typical analogue recordings under the five test conditions from one dog are shown in Fig. 1 . The results of the caval occlusion runs and for dP/dtmax at matched LVEDV are shown in Table I . Results for E,, and Mw are shown in Fig. 2 .
The correlation coefficients for the P,,-Ve regressions averaged 0.989, ranging from 0.904 to 0.999. For the SW-EDV relation the average value was 0.989, with a range from 0.866 to 0.999. As previously shown in our lab (6), increased heart rate caused a monotonic increase in contractility, as reflected by E,:. E, was progressively larger with each increase in rate before the administration of dobutamine; the addition of dobutamine caused a further marked increase of contractility. The value of E.> for D160 was greater than that for C160 (P < 0.002), and the value for D200 was greater than that for C200 (P < 0.002). Also, the contractile response to dobutamine appeared to be additive, since Es was larger for D200 than it was for D160 (P < 0.01).
The values for V100 demonstrate that this parameter was very similar at different heart rates before addition of dobutamine, but was smaller at both rates after the addition of dobutamine. Thus, not only does the relation have a steeper slope at any given heart rate after the addition of dobutamine, but it also is shifted to the left in the range of pressures measured in the experiment. Increased heart rate after dobutamine infusion does not further shift the relation to the left.
The dP/dtma,, data show that before dobutamine infusion dP/dtmax tended to increase with increased rate; these differences were not statistically significant. Dobutamine increased dP/dtmax at both heart rates tested, and the values for D200 were significantly greater than those of D160 (P < 0.01), suggesting an additive effect of heart rate and dobutamine on this parameter.
Unlike the other indexes of contractility, Mw decreased as heart rate increased. The value at C200 was lower than the values at either C120 or C160 (P < 0.01 and P < 0.002, respectively). The value at D160 was lower than any of the control runs, and was not further reduced by pacing to a rate of 200.
Vwwoo was higher at C200 when compared to either C120 or C160 (P > 0.02 for both comparisons). Thus, under control conditions increasing heart rate moved this relationship to the right, indicating reduced performance in terms of stroke work, or work done ejecting blood into the circulatory bed. Vw1ooo was smaller at both D160 and D200 when compared to all of the heart rates under control conditions (P < 0.02 for all comparisons). This indicates that dobutamine, unlike pacing tachycardia, increased performance in terms of stroke work. Table II . Single beats with closely matched LVEDP were chosen from runs under the different conditions in each dog. SW from a given LVEDV was progressively reduced by increasing heart rate: the value at C160 was smaller than that at C120 (P < 0.004), and fell further at C200 (P < 0.002 vs C160). Stroke work was increased at any heart rate by dobutamine infusion (P < 0.002 for comparisons at 160 and 200 bpm). Also, increasing heart rate during dobutamine infusion led to an increase in SW (P < 0.02), as opposed to the decrease in SW that occurred with increased heart rate under control conditions. The PVA from a given LVEDV also decreased with increased heart rate under control conditions. The values for C160 and C200 were both lower than those for C120 (P < 0.004). PVA was, however, increased at any heart rate dur- ing dobutamine infusion (P < 0.002). After dobutamine infusion PVA was not reduced by increasing heart rate. TransPvA, reflecting the percentage of PVA transferred to the peripheral circulation as SW, was not affected by increased heart rate under control conditions. TransPvA was increased at both heart rates after the addition of dobutamine (P < 0.002).
Also, TransPvA was increased further by increased heart rate after dobutamine infusion, from 73.6±5.8 to 79.4±5.4% (P < 0.02).
Effects ofpacing and dobutamine on effective arterial elastance. Fig. 3 shows the Ea data under the five sets of test conditions. Ea increased from 14.2±4.5 mmHg/ml at C120 to 19.6±8.8 and 24.2+±10.4 mmHg/ml at C160 and C200 respectively (P < 0.25 and P < 0.001). The addition of dobutamine reduced Ea at any heart rate. Ea at D160 was 16.0±8.1 mmHg/ml (P < 0.025 vs C 160), and was 17.7±7.3 mmHg/ml at D200 (P < 0.025 vs C200). Of note, the value at D200 was not significantly higher than that at D160, indicating that dobutamine blunted the effect of increased rate on Ea seen under control conditions. 
Discussion
The results of this study indicate that while both increased heart rate and dobutamine infusion increase myocardial contractility, they have substantially different effects on overall cardiovascular performance because of divergent effects on the vasculature. These two inotropic stimuli have different effects on arterial elastance and on the efficiency of energy transfer from PVA to SW. Thus, vascular properties play an important role in modulating how changes in contractility will be transmitted to the circulation.
As previously shown (6) , increasing heart rate from 120 to 200 bpm produces a moderate and incremental increase in contractility, reflected by Ees. In addition, increased heart rate causes an increase in the effective elastance of the systemic arterial bed, quantified as Ea. The vascular response we measured is predicted by the model of Sunagawa et al. (20) in which Ea is inversely related to cardiac cycle length. Ea, the ratio of end-systolic pressure (P.S) to stroke volume, depends not only on the material properties of the arterial system, but also on the arterial pressure when the aortic valve opens. During tachycardia, when the time for diastolic decay of the arterial pressure wave is shortened, the pressure at aortic valve opening will be higher, thus Pa and Ea will be increased.
Changes in the total peripheral resistance also affect E.: if vascular resistance increases, so will Ea (20). Mangel et al. (2 1) have shown in rabbits that the aorta has rhythmic contractile activity, which is synchronized with the pulse pressure waves. They found that the aorta relaxes during the rise in pulse pressure, a response that would tend to reduce Ea. It is possible that at heart rates markedly higher than those normally present in the animal this mechanism is saturated, and full relaxation does not occur. This could have added to the increase in Ea noted during rapid tachycardia in our experiments.
In contrast to the effect of heart rate on E(S,, another index of contractile performance, Mw, was reduced at higher heart rates. Since Mw is based on stroke work, which may be sensitive to alterations in arterial properties of the magnitude seen in this study, the reduction of Mw concurrent with an elevation in E. is not surprising.
How vascular changes determine if increased contractility will translate into improved overall cardiac performance can be seen by assessing the performance of the LV in terms of PVA and SW from a common LVEDV before and after increasing heart rate. Although contractility went up, both PVA and SW were decreased (Fig. 5) 16 .0±8.1 mmHg/ml at D160. Additionally, after dobutamine infusion arterial elastance did not go up in response to increases in heart rate. In fact, rapid pacing after dobutamine infusion led to an increase in PVA and SW, not a decrease. Thus, in addition to increasing contractility, dobutamine has important effects on the vasculature which augment its effect on LV performance. These effects likely result from the known vasodilatory properties of this agent, which result from peripheral beta adrenergically mediated smooth muscle relaxation (22) . It is interesting that these two contractile stimuli appear to be additive. A body of data supports the notion that contractility is dependent on levels of free intracellular calcium (see 23 for review). During increases in heart rate this may in part result from augmented sodium-calcium exchange, not related to slow-channel-mediated calcium influx (24) . Also, while action potential duration for each beat is shorter at faster rates, the total time spent in the depolarized phase per minute rises (25) A second potential problem is the use of Ea from a single beat to assess the systemic vasculature. We used the first beat of each occlusion, since this beat is measured before substantial change in loading conditions occurs. While beats at various points in the caval occlusion were used to compare dP/dtmI,, PVA, and SW, use ofEa based on a single LV pressure-volume loop during caval occlusion (nonsteady state) may not accurately represent arterial elastance (20). We reasoned that steady state Ea provides a reasonable estimate of the arterial parameters and related it to the composite index of contractility, E,,, as well as to single beat estimates of LV performance during the caval occlusions. A more precise estimate ofarterial elastance during individuaflbeats may provide a more accurate way to evaluate instantaneous ventriculovascular coupling.
Finally, it should be pointed out that these studies were carried out after autonomic blockade with atropine and hexamethonium, and after anesthesia. While these data provide an insight into myocardial and vascular response to two inotropic stimuli, in conscious, autonomically intact animals further factors may play a role.
In summary, our data confirm that both increased heart rate and dobutamine lead to increased myocardial contractility, and that these stimuli are additive. How well this increase in contractility is transmitted to the circulatory bed is modulated by the response of the vasculature. Thus, ventriculovascular coupling plays an important role in determining the response of the heart to inotropic stimulation. An assessment of pump performance, reflective of the effects of such stimuli on both the heart and the vasculature will provide the best measure of their overall effect on cardiac function.
